Does TOCILIZUMAB Cause Thrombocytopenia? 966 Reports in FDA Database

Q: Does TOCILIZUMAB cause Thrombocytopenia?

966 reports of Thrombocytopenia have been filed with the FDA for TOCILIZUMAB, representing 1.0% of all TOCILIZUMAB adverse event reports.

Q: How dangerous is Thrombocytopenia from TOCILIZUMAB?

Of 966 reports, 308 (31.9%) resulted in death and 308 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 966 reports of Thrombocytopenia have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 1.0% of all adverse event reports for TOCILIZUMAB.

966

Reports of Thrombocytopenia with TOCILIZUMAB

1.0%

of all TOCILIZUMAB reports

308

Deaths

308

Hospitalizations

How Dangerous Is Thrombocytopenia From TOCILIZUMAB?

Of the 966 reports, 308 (31.9%) resulted in death, 308 (31.9%) required hospitalization, and 157 (16.3%) were considered life-threatening.